Amarantus initiates CLIA development of Alzheimer’s blood diagnostic LymPro Test®
Amarantus announced an agreement with ICON for global therapeutic and diagnostic clinical development services. Amarantus has submitted a work order to ICON for delivery of the Fit for Purpose Flow Cytometry Assay Validation of the company’s flagship Alzheimer’s blood diagnostic LymPro Test®. September 02, 2014